Regeneron Pharmaceuticals, Inc.
REGN
•Stock Analysis$521.00
+0.00 (+0.00%)• Live
Regeneron Pharmaceuticals, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Regeneron Pharmaceuticals, Inc.
Key Financial Metrics
for Regeneron Pharmaceuticals, Inc.
P/E Ratio
12.30
Revenue Growth
+8.27%
EPS Growth
+10.39%
Market Cap
$55.05B
Dividend Yield
+0.34%
Debt/Equity
0.09
ROIC
+10.24%
FCF Yield
+5.49%
View additional metrics
Valuation
P/B Ratio1.88
EV/Sales3.88
Financial Health
Current Ratio4.93
Return on Assets+12.37%
Analyst Recommendations
for Regeneron Pharmaceuticals, Inc.
47 analysts
Consensus: Buy
About
for Regeneron Pharmaceuticals, Inc.
Company Details
for Regeneron Pharmaceuticals, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Leonard S. Schleifer
Employees
15,158
Market Cap
55.30B
Exchange
NASDAQ Global Select
IPO Date
April 2, 1991
Website
www.regeneron.comCIK
0000872589
ISIN
US75886F1075
CUSIP
75886F107
Country
US
Balance Sheet
for Regeneron Pharmaceuticals, Inc.
Cash Flow Statement
for Regeneron Pharmaceuticals, Inc.
Income Statement
for Regeneron Pharmaceuticals, Inc.
News
No news available at the moment.